Paul W. Schaffer - Net Worth and Insider Trading

Paul W. Schaffer Net Worth

The estimated net worth of Paul W. Schaffer is at least $95 dollars as of 2024-06-13. Paul W. Schaffer is the Director of Panbela Therapeutics Inc and owns about 238 shares of Panbela Therapeutics Inc (PBLA) stock worth over $95. Details can be seen in Paul W. Schaffer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul W. Schaffer has not made any transactions after 2020-09-08 and currently still holds the listed stock(s).

Transaction Summary of Paul W. Schaffer

To

Paul W. Schaffer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul W. Schaffer owns 1 companies in total, including Panbela Therapeutics Inc (PBLA) .

Click here to see the complete history of Paul W. Schaffer’s form 4 insider trades.

Insider Ownership Summary of Paul W. Schaffer

Ticker Comapny Transaction Date Type of Owner
PBLA Panbela Therapeutics Inc 2020-09-08 director

Paul W. Schaffer Latest Holdings Summary

Paul W. Schaffer currently owns a total of 1 stock. Paul W. Schaffer owns 238 shares of Panbela Therapeutics Inc (PBLA) as of September 8, 2020, with a value of $95.

Latest Holdings of Paul W. Schaffer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PBLA Panbela Therapeutics Inc 2020-09-08 238 0.40 95

Holding Weightings of Paul W. Schaffer


Paul W. Schaffer Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul W. Schaffer has made a total of 1 transactions in Panbela Therapeutics Inc (PBLA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Panbela Therapeutics Inc is the acquisition of 31 shares on September 8, 2020, which cost Paul W. Schaffer around $62,750.

Insider Trading History of Paul W. Schaffer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul W. Schaffer Trading Performance

GuruFocus tracks the stock performance after each of Paul W. Schaffer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul W. Schaffer is 40.64%. GuruFocus also compares Paul W. Schaffer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul W. Schaffer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Paul W. Schaffer's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Paul W. Schaffer

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 24.7 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 21.25 LIMIT LIMIT LIMIT LIMIT LIMIT

Paul W. Schaffer Ownership Network

Ownership Network List of Paul W. Schaffer

No Data

Ownership Network Relation of Paul W. Schaffer

Insider Network Chart

Paul W. Schaffer Owned Company Details

What does Panbela Therapeutics Inc do?

Who are the key executives at Panbela Therapeutics Inc?

Paul W. Schaffer is the director of Panbela Therapeutics Inc. Other key executives at Panbela Therapeutics Inc include director & President and CEO Jennifer K. Simpson , V.P. of Finance & CFO Susan Horvath , and 10 percent owner Ryan Randall Gilbertson .

Panbela Therapeutics Inc (PBLA) Insider Trades Summary

Over the past 18 months, Paul W. Schaffer made no insider transaction in Panbela Therapeutics Inc (PBLA). Other recent insider transactions involving Panbela Therapeutics Inc (PBLA) include a net sale of 72,874 shares made by Goldman Sachs Group Inc , a net purchase of 4,444 shares made by Susan Horvath , and a net purchase of 4,444 shares made by Jennifer K. Simpson .

In summary, during the past 3 months, insiders sold 0 shares of Panbela Therapeutics Inc (PBLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,644 shares of Panbela Therapeutics Inc (PBLA) were sold and 15 shares were bought by its insiders, resulting in a net sale of 3,629 shares.

Panbela Therapeutics Inc (PBLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Panbela Therapeutics Inc Insider Transactions

No Available Data

Paul W. Schaffer Mailing Address

Above is the net worth, insider trading, and ownership report for Paul W. Schaffer. You might contact Paul W. Schaffer via mailing address: 712 Vista Blvd #305, Waconia Mn 55387.

Discussions on Paul W. Schaffer

No discussions yet.